Preparation, Characterization and Evaluation of Quetiapine Fumarate Solid Lipid Nanoparticles to Improve the Oral Bioavailability

Figure 3

Cumulative % drug release from quetiapine fumarate SLNs in pH 6.8 phosphate buffer.